Ricardo E. Bruges - Publications

Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: June 06, 2026

Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non-small cell lung cancer: the RECAPC multicenter registry.

Journal: Frontiers in oncology

Published: April 23, 2026

Clinical and prognostic factors in pleural mesothelioma: insights from a Latin American cohort.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 19, 2026

Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 24, 2025

Cancer care under systemic shock: utilization declines and cost increases during the COVID-19 pandemic in Colombia, evidence from matched administrative cohorts.

Journal: Archives of public health = Archives belges de sante publique

Published: May 22, 2025

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 21, 2024

Advanced Breast Cancer Guidelines in Latin America: Assessment, Adaptation, and Implementation of Fifth Advanced Breast Cancer Consensus Guidelines.

Journal: JCO global oncology

Published: February 01, 2024

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 15, 2023

A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.

Journal: Future oncology (London, England)

Published: March 15, 2023

Impact of vaccination against COVID-19 on patients with cancer in ACHOC-C19 study: Real world evidence from one Latin American country.

Journal: Journal of Cancer

Published: October 18, 2022

Two Unusual Mutations in the Epidermal Growth Factor Receptor Gene in a Patient With Lung Adenocarcinoma.

Journal: Cureus

Published: February 18, 2022

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.

Journal: Nature

Published: October 22, 2021